Intellectual Property India Publishes Patent Application for 'Application Of Trimethylsulfoxonium Bromide In The Preparation Of Intermediates' Filed by RK Pharma Inc

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202441017240 A) filed by RK Pharma Inc, RK Pharma Inc, Pearl River, U.S.A., on March 11, 2024, for 'application of trimethylsulfoxonium bromide in the preparation of intermediates.'

Inventor(s) include Ravishanker Kovi; Murali Krishna Madala; Sureshkumar Kanagaraj; Moorkonda Raja Sekhar; Gajula Chennakesava Rao; Karnati Sudharshan Reddy; and Konjeti Murali Krishna.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides an use of Trimethylsulfoxonium bromide in an improved, commercially viable, cost effective and industrially scalable process for the preparation of Raltegravir intermediate, Cevimeline Intermediate, Fluconazole and 1-[[2- (2,4-Difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazolemethane sulphonate."

Disclaimer: Curated by HT Syndication.